A detailed history of Paladin Advisory Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Paladin Advisory Group, LLC holds 1,356 shares of EW stock, worth $94,621. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,356
Previous 1,356 -0.0%
Holding current value
$94,621
Previous $125,000 28.8%
% of portfolio
0.07%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$74.26 - $84.51 $100,696 - $114,595
1,356 New
1,356 $112,000
Q1 2022

Apr 15, 2022

BUY
$101.96 - $128.34 $138,257 - $174,029
1,356 New
1,356 $166,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Paladin Advisory Group, LLC Portfolio

Follow Paladin Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paladin Advisory Group, LLC with notifications on news.